<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The objective was to compare the contribution to perinatal <z:e sem="disease" ids="C0020433" disease_type="Disease or Syndrome" abbrv="">bilirubinemia</z:e> of <z:mp ids='MP_0010163'>hemolysis</z:mp> and <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronosyltransferase (UGT) gene promoter polymorphism, seen in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, between <z:chebi fb="105" ids="17234">glucose</z:chebi>-6-phosphate dehydrogenase (G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>)-deficient and -<z:mpath ids='MPATH_458'>normal</z:mpath> neonates </plain></SENT>
<SENT sid="1" pm="."><plain>Serum total <z:chebi fb="0" ids="16990">bilirubin</z:chebi> (STB) values from 52 G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficient and 166 G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-<z:mpath ids='MPATH_458'>normal</z:mpath> term, male neonates, sampled within 3 h of delivery (first sample) and on d 3 (second sample), were analyzed in relation to blood carboxyhemoglobin corrected for inspired CO (COHbc), an accurate index of <z:mp ids='MP_0010163'>hemolysis</z:mp>, and UGT promoter genotype </plain></SENT>
<SENT sid="2" pm="."><plain>COHbc values (% total Hb) were greater in G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficient neonates than controls: first sample 1.00 +/- 0.25% versus 0.84 +/- 0.24%, p &lt; 0.0001; second sample 0.83 +/- 0.20% versus 0.76 +/- 0.19%, p = 0.002 </plain></SENT>
<SENT sid="3" pm="."><plain>First sample COHbc and STB values did not correlate in either the G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficient or control groups, whereas second sample COHbc values correlated significantly with corresponding STB values in the control population only (r = 0.28, p = 0.0007) </plain></SENT>
<SENT sid="4" pm="."><plain>At second sampling, there was a higher allele frequency of the variant UGT promoter among those with STB values &gt; or =75th percentile than those &lt;75th among the G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficient neonates (0.60 versus 0.33, respectively, p = 0.025), but not controls (0.31 versus 0.40, respectively, p = 0.24) </plain></SENT>
<SENT sid="5" pm="."><plain>Among those infants with at least one variant UGT promoter allele, STB values were higher in the G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficient neonates than controls at second sampling only (181 +/- 56 microM versus 149 +/- 46 microM, respectively, p = 0.03) </plain></SENT>
<SENT sid="6" pm="."><plain>Both within and between the G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficient and control groups, our data demonstrate changing and differing contributions of <z:mp ids='MP_0010163'>hemolysis</z:mp> and UGT promoter polymorphism to <z:e sem="disease" ids="C0020433" disease_type="Disease or Syndrome" abbrv="">bilirubinemia</z:e> during the first 3 d of life </plain></SENT>
</text></document>